Nathan Pieri Sells 9,862 Shares of Amber Road Inc (NYSE:AMBR) Stock

Share on StockTwits

Amber Road Inc (NYSE:AMBR) insider Nathan Pieri sold 9,862 shares of the firm’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $13.00, for a total value of $128,206.00. Following the transaction, the insider now owns 9,862 shares of the company’s stock, valued at $128,206. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Nathan Pieri also recently made the following trade(s):

  • On Tuesday, May 21st, Nathan Pieri sold 121,279 shares of Amber Road stock. The stock was sold at an average price of $12.97, for a total value of $1,572,988.63.
  • On Tuesday, May 14th, Nathan Pieri sold 114,589 shares of Amber Road stock. The stock was sold at an average price of $12.97, for a total value of $1,486,219.33.

AMBR stock traded up $0.01 during mid-day trading on Friday, reaching $13.00. The company’s stock had a trading volume of 16,204 shares, compared to its average volume of 421,856. The company has a market cap of $377.54 million, a P/E ratio of -26.53 and a beta of -0.05. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.60 and a current ratio of 0.60. Amber Road Inc has a 12 month low of $7.60 and a 12 month high of $13.03.

Amber Road (NYSE:AMBR) last issued its earnings results on Thursday, May 9th. The software maker reported ($0.08) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.10) by $0.02. The business had revenue of $21.10 million during the quarter, compared to the consensus estimate of $20.62 million. Amber Road had a negative return on equity of 33.06% and a negative net margin of 12.49%. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the previous year, the company posted ($0.04) earnings per share. On average, research analysts predict that Amber Road Inc will post -0.33 earnings per share for the current year.

A number of equities research analysts have weighed in on AMBR shares. LADENBURG THALM/SH SH downgraded Amber Road from a “buy” rating to a “neutral” rating in a report on Monday, May 13th. Zacks Investment Research downgraded Amber Road from a “hold” rating to a “sell” rating in a report on Thursday, March 28th. Needham & Company LLC downgraded Amber Road from a “buy” rating to a “hold” rating and set a $12.95 target price for the company. in a report on Tuesday, May 14th. Finally, ValuEngine upgraded Amber Road from a “hold” rating to a “buy” rating in a report on Friday, May 10th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $13.98.

A number of hedge funds have recently modified their holdings of the business. Royce & Associates LP increased its holdings in shares of Amber Road by 7.0% during the fourth quarter. Royce & Associates LP now owns 1,868,815 shares of the software maker’s stock valued at $15,380,000 after acquiring an additional 122,896 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Amber Road by 6.2% during the fourth quarter. BlackRock Inc. now owns 1,561,136 shares of the software maker’s stock valued at $12,847,000 after acquiring an additional 91,376 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Amber Road by 16.5% during the third quarter. Vanguard Group Inc. now owns 1,205,262 shares of the software maker’s stock valued at $11,594,000 after acquiring an additional 170,725 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Amber Road by 20.6% during the first quarter. Renaissance Technologies LLC now owns 1,039,100 shares of the software maker’s stock valued at $9,009,000 after acquiring an additional 177,500 shares in the last quarter. Finally, Divisar Capital Management LLC increased its holdings in shares of Amber Road by 5.6% during the fourth quarter. Divisar Capital Management LLC now owns 759,660 shares of the software maker’s stock valued at $6,252,000 after acquiring an additional 40,000 shares in the last quarter. Institutional investors and hedge funds own 79.65% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.tickerreport.com/banking-finance/4371663/nathan-pieri-sells-9862-shares-of-amber-road-inc-nyseambr-stock.html.

About Amber Road

Amber Road, Inc provides cloud-based global trade management (GTM) solutions in the United States and internationally. The company's GTM solutions include modules, such as import management, export management, China trade management, global logistics management, trade agreement management, and supply chain collaboration, as well as professional services, such as assessment, implementation, education and training, and maintenance and support.

Featured Article: How Do You Calculate Return on Investment (ROI)?

Insider Buying and Selling by Quarter for Amber Road (NYSE:AMBR)

Receive News & Ratings for Amber Road Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amber Road and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Central European Media Enterprises  and Liberty Braves Group Series A  Head-To-Head Review
Central European Media Enterprises and Liberty Braves Group Series A Head-To-Head Review
Financial Review: Pagerduty  versus Qumu
Financial Review: Pagerduty versus Qumu
Reviewing Chromadex  & CV Sciences
Reviewing Chromadex & CV Sciences
Analyzing Verb Technology  & UniFirst
Analyzing Verb Technology & UniFirst
Cytosorbents  and Globus Medical  Head-To-Head Analysis
Cytosorbents and Globus Medical Head-To-Head Analysis
Head to Head Contrast: JMU Ltd-  & MTECH ACQUISITI/SH CL A
Head to Head Contrast: JMU Ltd- & MTECH ACQUISITI/SH CL A


© 2006-2019 Ticker Report